Literature DB >> 15585081

Substitution of HIV Type 1 Nef with HTLV-1 p12.

Tomonori Tsukahara1, Lee Ratner.   

Abstract

Human retroviruses, such as HTLV-1 and HIV-1, encode accessory proteins, which regulate viral pathogenesis. The p12 protein of HTLV-1 is encoded from the pX-I open reading frame, and is critical for efficient virus replication in rabbits. Although dispensable for infection, replication, and immortalization of activated lymphocytes in culture, p12 expression is important for infection of quiescent lymphocytes. Similar to HTLV-1 p12, Nef is important for virus infectivity in SIV animal models. We questioned whether p12 could replace Nef in HIV-1, and reconstitute virus replication in culture. We found that p12 could complement for effects of Nef on HIV-1 infection of Magi-CCR5 cells or macrophages.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15585081      PMCID: PMC2652723          DOI: 10.1089/aid.2004.20.938

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  37 in total

1.  Synergistic activation of NFAT by HIV-1 nef and the Ras/MAPK pathway.

Authors:  A Manninen; G H Renkema; K Saksela
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

2.  Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions.

Authors:  E Schaeffer; R Geleziunas; W C Greene
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes.

Authors:  B Albrecht; N D Collins; M T Burniston; J W Nisbet; L Ratner; P L Green; M D Lairmore
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Human T-cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes.

Authors:  M D Robek; F H Wong; L Ratner
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  HIV-1 Nef increases T cell activation in a stimulus-dependent manner.

Authors:  J A Schrager; J W Marsh
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

6.  Rapid phenotypic drug susceptibility assay for HIV-1 with a CCR5 expressing indicator cell line.

Authors:  M Pirounaki; N A Heyden; M Arens; L Ratner
Journal:  J Virol Methods       Date:  2000-03       Impact factor: 2.014

7.  HIV-Nef enhances interleukin-2 production and phosphatidylinositol 3-kinase activity in a human T cell line.

Authors:  S D Schibeci; A O Clegg; R A Biti; K Sagawa; G J Stewart; P Williamson
Journal:  AIDS       Date:  2000-08-18       Impact factor: 4.177

8.  Induction of Bcl-x(L) expression by human T-cell leukemia virus type 1 Tax through NF-kappaB in apoptosis-resistant T-cell transfectants with Tax.

Authors:  T Tsukahara; M Kannagi; T Ohashi; H Kato; M Arai; G Nunez; Y Iwanaga; N Yamamoto; K Ohtani; M Nakamura; M Fujii
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

9.  Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo.

Authors:  N D Collins; G C Newbound; B Albrecht; J L Beard; L Ratner; M D Lairmore
Journal:  Blood       Date:  1998-06-15       Impact factor: 22.113

10.  Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain.

Authors:  X N Xu; B Laffert; G R Screaton; M Kraft; D Wolf; W Kolanus; J Mongkolsapay; A J McMichael; A S Baur
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

View more
  6 in total

1.  The SCHOOL of nature: III. From mechanistic understanding to novel therapies.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-06-11

2.  The SCHOOL of nature: IV. Learning from viruses.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-10

3.  MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1.

Authors:  Massimo Pizzato
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

Review 4.  Pathogenesis and treatment of human T-cell leukemia virus infection.

Authors:  Lee Ratner
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 5.  Viral pathogenesis, modulation of immune receptor signaling and treatment.

Authors:  Walter M Kim; Alexander B Sigalov
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 6.  SCHOOL model and new targeting strategies.

Authors:  Alexander B Sigalov
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.